196 related articles for article (PubMed ID: 25546515)
21. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells.
Medjane S; Raymond B; Wu Y; Touqui L
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L816-24. PubMed ID: 15964894
[TBL] [Abstract][Full Text] [Related]
22. Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling.
Hunter MJ; Treharne KJ; Winter AK; Cassidy DM; Land S; Mehta A
PLoS One; 2010 Jul; 5(7):e11598. PubMed ID: 20644644
[TBL] [Abstract][Full Text] [Related]
23. NF-κB and androgen receptor variant expression correlate with human BPH progression.
Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW
Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083
[TBL] [Abstract][Full Text] [Related]
24. IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
Li Y; Shi J; Qi S; Zhang J; Peng D; Chen Z; Wang G; Wang Z; Wang L
J Exp Clin Cancer Res; 2018 Aug; 37(1):196. PubMed ID: 30119635
[TBL] [Abstract][Full Text] [Related]
25. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
[TBL] [Abstract][Full Text] [Related]
26. Regulation of cell proliferation through a KIT-mediated mechanism in benign prostatic hyperplasia.
Imura M; Kojima Y; Kubota Y; Hamakawa T; Yasui T; Sasaki S; Hayashi Y; Kohri K
Prostate; 2012 Oct; 72(14):1506-13. PubMed ID: 22314612
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
28. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of the large-conductance Ca(2+)-activated K+ channel, K(Ca)1.1 in the prostatic stromal cells of benign prostate hyperplasia.
Niwa S; Ohya S; Kojima Y; Sasaki S; Yamamura H; Sakuragi M; Kohri K; Imaizumi Y
Biol Pharm Bull; 2012; 35(5):737-44. PubMed ID: 22687410
[TBL] [Abstract][Full Text] [Related]
31. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
32. Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-kappaB activation.
Kim JM; Lee JY; Yoon YM; Oh YK; Kang JS; Kim YJ; Kim KH
Eur J Immunol; 2006 Sep; 36(9):2446-56. PubMed ID: 16892182
[TBL] [Abstract][Full Text] [Related]
33. Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
Rick FG; Abi-Chaker A; Szalontay L; Perez R; Jaszberenyi M; Jayakumar AR; Shamaladevi N; Szepeshazi K; Vidaurre I; Halmos G; Krishan A; Block NL; Schally AV
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2617-22. PubMed ID: 23359692
[TBL] [Abstract][Full Text] [Related]
34. Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-κB and MAP kinases in lipopolysaccharide-treated PC12 cells.
Geng Y; Fang M; Wang J; Yu H; Hu Z; Yew DT; Chen W
Phytother Res; 2012 Mar; 26(3):337-43. PubMed ID: 21717513
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia.
Abo-El Fetoh ME; Abdel-Fattah MM; Mohamed WR; Ramadan LAA; Afify H
Inflammopharmacology; 2023 Feb; 31(1):499-516. PubMed ID: 36586043
[TBL] [Abstract][Full Text] [Related]
37. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property.
Lin VK; Wang SY; Vazquez DV; C Xu C; Zhang S; Tang L
Prostate; 2007 Sep; 67(12):1265-76. PubMed ID: 17597114
[TBL] [Abstract][Full Text] [Related]
38. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
39. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
40. Urban particulate matter down-regulates filaggrin via COX2 expression/PGE2 production leading to skin barrier dysfunction.
Lee CW; Lin ZC; Hu SC; Chiang YC; Hsu LF; Lin YC; Lee IT; Tsai MH; Fang JY
Sci Rep; 2016 Jun; 6():27995. PubMed ID: 27313009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
